1Reddy, KS. Cardiovascular diseases in the developing countries: dimensions, determinants, dynamics and directions for public health action. Public Health Nutrition 2002; 5: 231–7.
2The World Health Report 1999: making a difference. Geneva: World Health Organization, 1999.
3Murray, CJL, Lopez, AD. Global Health Statistics. Global Burden of Disease and Injury Series. Boston, MA: Harvard School of Public Health, 1996.
4Reddy, KS, Yusuf, S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998; 97: 569–601.
5Yusuf, S, Reddy, S, Ounpuu, S, Anand, S. Global burden of cardiovascular diseases. Part I: general considerations, the epidemiological transition, risk factors, and impact of urbanization. Circulation 2001; 104: 2746.
6Yusuf, S, Reddy, S, Ounpuu, S, Anand, S. Global burden of cardiovascular diseases. Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001; 104: 2855.
7Clayton, D, McKeigue, PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 2001; 358(9290): 1356–60.
8Krause, BR, Princen, HMG. Lack of predictability of classical animal models for hypolipidemic activity: a good time for mice?. Atherosclerosis 1998; 140: 15–24.
9Stephens, NG, Parsons, A, Schofield, PM, et al. Randomized controlled trial of Vitamin E in patients with coronary disease; Cambridge Heart Anti–oxidant Study (CHAOS). Lancet 1996; 347: 781–6.
10Verschuren, WMM, Jacobs, DR, Bloemberg, BPM, et al. Serum total cholesterol and long–term coronary heart disease mortality in different cultures: twenty–five year follow–up of the Seven Country Study. Journal of the American Medical Association 1995; 274: 131–6.
11De Lorgeril, M, Salen, P, Martin, JL, et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of Lyon Diet Heart Study. Circulation 1999; 99: 779–85.
12Willett, WC. Nutritional Epidemiology. New York: Oxford University Press, 1998.
13Kris-Etherton, P, Daniels, SR, Eckel, RH, et al. for the Nutrition Committee of the American Heart Association, Summary of the Scientific Conference on Dietary Fatty Acids and Cardiovascular Health. Circulation 2001; 103: 1034–9.
14Cutler, JA, Follmann, D, Allender, PS. Randomized trials of sodium reduction: an overview. American Journal of Clinical Nutrition 1997; 65(Suppl. 2): 643S–51S.
15Assmann, G, Schulte, H. Relation of high–density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). American Journal of Cardiology 1992; 70: 733–7.
16Hopkins, PN. Effects of dietary cholesterol on serum cholesterol: a meta–analysis and review. American Journal of Clinical Nutrition 1992; 55: 1060–70.
17Weggemans, RM, Zock, PL, Katan, MB. Dietary cholesterol from eggs increases the ratio of total cholesterol to high–density lipoprotein cholesterol in humans: a meta–analysis. American Journal of Clinical Nutrition 2001; 73: 885–91.
18Katan, MJ, Zock, PL, Mensink, RP. Dietary oils, serum lipoproteins and coronary heart disease. American Journal of Clinical Nutrition 1995; 61(Suppl.): 1368S–73S.
19Hu, F, Stampfer, MJ, Manson, JE, et al. Dietary fat intake and the risk of coronary heart disease in women. New England Journal of Medicine 1994; 337: 1491–9.
20Kromhout, D, Menotti, A, Bloemberg, B, et al. Dietary saturated and trans fatty acids and cholesterol and 25–year mortality from coronary heart disease: the Seven Countries Study. Preventive Medicine 1995; 24: 308–15.
21Mensink, RP, Katan, MB. Effect of dietary fatty acids on serum lipids and lipoproteins—a meta–analysis of 27 trials. Arteriosclerosis and Thrombosis 1992; 12: 911–9.
22Sacks, F. Dietary fats and coronary heart disease. Journal of Cardiovascular Risk 1994; 1: 3–8.
23de Roos, NM, Schouten, EG, Katan, MB. Trans fatty acids, HDL–cholesterol, and cardiovascular disease. Effects of dietary changes on vascular reactivity. European Journal of Medical Research 2003; 8: 355–7.
24Judd, JT, Clevidence, BA, Muesing, RA, et al. Dietary trans fatty acids: effects of plasma lipids and lipoproteins on healthy men and women. American Journal of Clinical Nutrition 1994; 59: 861–8.
25Willett, WC, Stampfer, MJ, Manson, JE, et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993; 341: 581–5.
26Ascherio, A, Rimm, EB, Giovannucci, EL, et al. Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. British Medical Journal 1996; 313: 84–90.
27Oomen, CM, Ocke, MC, Feskens, EDM, et al. Association between trans fatty acid intake and 10–year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population—based study. Lancet 2001; 357: 746–51.
28Katan, MB. Trans fatty acids and plasma lipoproteins. Nutrition Reviews 2000; 58: 188–91.
29Kris-Etherton, PM. Monosaturated fatty acids and risk of cardiovascular disease. Circulation 1999; 100: 1253–8.
30Mori, TA, Beilin, LJ. Long–chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction. Current Opinion in Lipidology 2001; 12: 11–7.
31Mori, TA, Bao, DQ, Burke, V, et al. Purified eicosapentaenoic acid and docosahexaenoic acid have differential effects on serum lipids and lipoproteins, LDL–particle size, glucose and insulin, in mildly hyperlipidaemic men. American Journal of Clinical Nutrition 2000; 71: 1085–94.
32Harris, WS. n –3 Fatty acids and serum lipoproteins: human studies. American Journal of Clinical Nutrition 1997; 65: 1645S–54S.
33GISSI-Prevenzione Investigators. Dietary supplementation with n -3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI Prevenzione Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Lancet 1999; 354: 447–55.
34Von Schacky, C. n-3 fatty acids and the prevention of coronary atherosclerosis. American Journal of Clinical Nutrition 2000; 71(Suppl. 1): 224S–7S.
35Lemaitre, RN, King, IB, Raghunathan, TE, et al. Cell membrane trans –fatty acids and the risk of primary cardiac arrest. Circulation 2002; 105: 697–701.
36McLennan, PL, Abeywardena, MY, Charnock, JS. Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion. American Heart Journal 1998; 116: 709–17.
37Hetzel, BS, Charnock, JS, Dwyer, T, McLennan, PL. Fall in coronary heart disease mortality in U.S.A. and Australia due to sudden death: evidence for the role of polyunsaturated fat. Journal of Clinical Epidemiology 1989; 42: 885–93.
38Grundy, SM. What is the desirable ratio of saturated, polyunsaturated, and monounsaturated fatty acids in the diet?. American Journal of Clinical Nutrition 1997; 66(Suppl.): 988S–90S.
39Grundy, SM. The optimal ratio of fat–to–carbohydrate in the diet. Annual Review of Nutrition 1999; 19: 325–41.
40Willett, WC. Dietary fat plays a major role in obesity: no. Obesity Reviews 2002; 3: 59–68.
41Mendis, S, Samarajeewa, U, Thattil, O. Coconut fat and serum lipoproteins: effects of partial replacement with unsaturated fats. British Journal of Nutrition 2001; 85: 583–9.
42Knutzon, DS, Knauf, V. Manipulating seed oils for polyunsaturated fatty acid content. In: Harwood, J, ed. Plant Lipid Biosynthesis: Fundamentals and Agricultural Applications. Cambridge, UK: University Press Society for Experiment Biology Seminar Series, 1998; 287: 67.
43Truswell, AS. Food carbohydrates and plasma lipids—an update. American Journal of Clinical Nutrition 1994; 59(Suppl.): 710S–8S.
44Jenkins, DJA, Jenkins, AL, Wolever, TMS, et al. Low glycemic index: lente carbohydrates and physiological effects of altered food frequency. American Journal of Clinical Nutrition 1994; 59(Suppl.): 706S–9S.
45Liu, S, Willet, WC, Stampfer, MJ, et al. A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. American Journal of Clinical Nutrition 2000; 71: 1455–61.
46Marlett, JA. Content and composition of dietary fiber in 117 frequently consumed foods. Journal of the American Dietetic Association 1992; 92: 175–86.
47Shikany, JM, Ala, B, White, GL. Dietary guidelines for chronic disease prevention. Southern Medical Journal 2000; 93: 1138–51.
48Truswell, AS. Cereal grains and coronary heart disease. European Journal of Clinical Nutrition 2002; 56: 1–14.
49Ludwig, DS, Pereira, MA, Kroenke, CH, et al. Dietary fiber, weight gain, and cardiovascular risk factors in young adults. Journal of the American Medical Association 1999; 282: 1539–46.
50Liu, S, Stampfer, MJ, Hu, FB, et al. Whole grain consumption and the risk of coronary heart disease: from the Nurses' Health Study. American Journal of Clinical Nutrition 1999; 70: 412–9.
51Rimm, EB, Ascherio, A, Giovannucci, E, et al. Vegetable, fruit and cereal fiber intake and risk of coronary heart disease among men. Journal of the American Medical Association 1996; 275: 447–51.
52Rimm, EB, Stampfer, MJ. Antioxidants for vascular disease. Medical Clinics of North America 2000; 84: 239–49.
53Ness, AR. Commentary: beyond beta–carotene—antioxidants and cardiovascular disease. International Journal of Epidemiology 2001; 30: 143–4.
54Yusuf, S, Dagenais, G, Pogue, J, Sleight, P. Vitamin E supplementation and cardiovascular events in high–risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. New England Journal of Medicine 2000; 345: 154–60.
55Collaborative group, of the primary prevention project (PPP). Low–dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice. Lancet 2001; 357: 89–95.
56Stampfer, MJ, Malinow, MR, Willett, WC, et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. Journal of the American Medical Association 1992; 268: 877–81.
57Selhub, J, Jacques, PF, Bostom, AG, et al. Association between plasma homocysteine concentrations and extracranial carotid–artery stenosis. New England Journal of Medicine 1995; 332: 286–91.
58Stampfer, MJ, Malinow, MR, Willett, WC, et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. Journal of the American Medical Association 1992; 268: 877–81.
59Welch, GN, Loscalzo, J. Homocysteine and atherothrombosis. New England Journal of Medicine 1998; 338: 1042–50.
60Brouwer, IA, van Dusseldorp, M, Thomas, CM, et al. Low dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial. American Journal of Clinical Nutrition 1999; 69: 99–104.
61Scott, JM. Homocysteine and cardiovascular risk. American Journal of Clinical Nutrition 2000; 72: 333–4.
62Guttormsen, AB, Ueland, PM, Svarstad, E, Refsum, H. Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney International 1997; 52: 495–502.
63Celermajer, DS, Sorensen, K, Ryalls, M, et al. Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. Journal of the American College of Cardiology 1993; 22: 854–8.
64Bellamy, MF, McDowell, IF, Ramsey, MW, et al. Oral folate enhances endothelial function in hyperhomocysteinaemic subjects. European Journal of Clinical Investigation 1999; 29: 659–62.
65Rimm, EB, Willett, WC, Hu, FB, et al. Folate and Vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. Journal of the American Medical Association 1998; 279: 359–64.
66Tice, JA, Rose, E, Coxson, PG, et al. Cost–effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease. Effect of grain fortification and beyond. Journal of the American Medical Association 2001; 286: 936–43.
67Seshadri, N, Robinson, K. Homocysteine, B Vitamins, and coronary artery disease. Medical Clinics of North America 2000; 84: 215–37.
68Hertog, MGL, Feskens, EJM, Hollman, PCH, Katan, MB, Kromhout, D. Dietary antioxidant flavonoids and risk of coronary heart disease. The Zutphen elderly study. Lancet 1993; 342: 1007–11.
69Keli, SO, Hertog, MGL, Feskens, EJM, Kromhout, D. Dietary flavonoids, antioxidant vitamins and incidence of stroke. Archives of Internal Medicine 1996; 154: 637–42.
70Gibbs, CR, Lip, GYH, Beevers, DG. Salt and cardiovascular disease: clinical and epidemiological evidence. Journal of Cardiovascular Risk 2000; 7: 9–13.
71INTERSALT Cooperative, Research Group. INTERSALT: an international study of electrolyte excretion and blood pressure. Results for 24hr urinary sodium and potassium excretion. British Medical Journal 1988; 297: 319–28.
72Elliott, P, Stamler, J, Nicholas, R, Dyer, AR, Stamler, R, Marmot, M, et al. for the Intersalt Cooperative Research Group, Intersalt revisited: further analyses of 24hr sodium excretion and blood pressure within and across populations. British Medical Journal 1996; 312: 1249–55.
73Mancilha Carvalho, JJ, Baruzzi, RG, Howard, PF. Blood pressure in four remote populations in the Intersalt study. Hypertension 1989; 14: 238–46.
74Poulter, NK, Khaw, KT, Hopwood, BEC, Mugambi, M, Peart, WS, Rose, G, et al. The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. British Medical Journal 1990; 300: 967–72.
75Law, MR, Frost, MD, Wald, NJ. By how much does salt reduction lower blood pressure? III. Analysis of data from trials of salt reduction. British Medical Journal 1991; 302: 819–24.
76Tuomilehto, J, Jousilahti, P, Rastenyte, D, Moltchanov, V, Tanskanen, A, Pietinen, P, Nissinen, A. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001; 357: 848–51.
77Law, MR, Frost, CD, Wald, NJ 3rd. Analysis of data from trials of salt reduction. British Medical Journal 1991; 302: 819–24.
78Geleijnse, JM, Hofman, A, Witteman, JC, Hazebroek, AA, Valkenburg, HA, Grobbee, DE. Long–term effects of neonatal sodium restriction on blood pressure. Hypertension 1997; 29: 913–7. (Published erratum in Hypertension 1997; 29: 1211.).
79Whelton, PK, Appel, LJ, Espeland, MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons. Journal of the American Medical Association 1998; 279: 839–46.
80Sacks, FM, Svetkey, LP, Vollmer, WM, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. New England Journal of Medicine 2001; 344: 3–10.
81Schmieder, RE, Messerli, FH, Garavaglia, GE, Nunez, BD. Dietary salt intake. A determinent of cardiac involvement in essential hypertension. Circulation 1988; 78: 951–6.
82Liebson, PR, Grandits, GA, Dianzumba, S, et al. Comparision of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional–hygenic therapy in the Treatment of Mild Hypertension Study (TOHMS). Circulation 1995; 91: 698–706.
83Forte, JG, Miguel, JM, Miguel, MJ, et al. Salt and blood pressure: a community trial. Journal of Human Hypertension 1989; 3: 179–84.
84Tian, HG, Guo, ZY, Hu, G, et al. Changes in sodium intake and blood pressure in a community–based intervention project in China. Journal of Human Hypertension 1995; 9: 959–68.
85Staessen, J, Bulpitt, CJ, Fagard, R, et al. Salt intake and blood pressure in the general population: a controlled intervention trial in two towns. Journal of Hypertension 1988; 6: 965–73.
86Tobian, L, Hanlon, S. High sodium chloride diets injure arteries and raise mortality without raising blood pressure. Hypertension 1990; 15: 900–3.
87Xie, JX, Sasaki, S, Joossens, JV, Kesteloot, H. The relationship between urinary cations obtained from the INTERSALT study and cerebrovascular mortality. Journal of Human Hypertension 1992; 6: 17–21.
88Young, DB, Lin, H, McCabe, RD. Potassium's cardiovascular protective mechanisms. American Journal of Physiology 1995; 268: R825–37.
89Krishna, GG, Miller, E, Kapoor, S. Increased blood pressure during potassium depletion in normotensive men. New England Journal of Medicine 1989; 320: 1177–82.
90Whelton, PK, He, J, Cutler, JA, et al. Effects of oral potassium on blood pressure: meta–analysis of randomized controlled clinical trials. Journal of the American Medical Association 1996; 275: 1016–22.
91Khaw, KT, Barrett-Connor, E. Dietary potassium and stroke associated mortality. New England Journal of Medicine 1987; 316: 235–40.
92Griffith, LE, Guyatt, GH, Cook, RJ, et al. The influence of dietary and non–dietary calcium supplementation on blood pressure. An updated meta–analysis of randomized controlled trials. Journal of Hypertension 1999; 12: 84–92.
93Mizushima, S, Cuppauccio, FP, Nichols, R, Elliott, P. Dietary magnesium intake and blood pressure: a qualitative overview of the observational studies. Journal of Human Hypertension 1998; 12: 447–53.
94Nestle, M. Animal vs. plant foods in human diets and health: is the historical record unequivocal?. Proceedings of the Nutrition Society 1999; 58: 211–8.
95Law, MR, Morris, JK. By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease? European Journal of Clinical Nutrition 1998; 52: 549–56.
96Ness, AR, Powles, JW. Fruit and vegetables, and cardiovascular disease: a review. International Journal of Epidemiology 1997; 26: 1–13.
97Liu, S, Manson, JE, Lee, I-M, et al. Fruit and vegetable intake and risk of cardiovascular disease: the Women's Health Study. American Journal of Clinical Nutrition 2000; 72: 922–8.
98Liu, S, Lee, I-M, Ajani, U, et al. Intake of vegetables rich in carotenoids and risk of coronary heart disease in men: The Physicians' Health Study. International Journal of Epidemiology 2001; 30: 130–5.
99Joshipura, KJ, Ascherio, A, Manson, JF, et al. Fruit and vegetable intake in relation to risk of ischemic stroke. Journal of the American Medical Association 1999; 282: 1233–9.
100Appel, LJ, Moore, TJ, Obarzanek, E, et al. A clinical trial of the effects of dietary patterns on blood pressure. New England Journal of Medicine 1998; 336: 1117–24.
101Kromhout, D, Bosschieter, Eb, de Lezenne Coulander, C. The inverse relation between fish consumption and 20 year mortality from coronary heart disease. New England Journal of Medicine 1985; 312: 1205–9.
102Daviglus, ML, Stamler, J, Orencia, AJ, et al. Fish consumption and the 30–year risk of fatal myocardial infarction. New England Journal of Medicine 1997; 336: 1046–53.
103Marckmann, P, Gronbaek, M. Fish consumption and coronary heart disease mortality. A systematic review of prospective cohort studies. European Journal of Clinical Nutrition 1999; 53: 585–90.
104Burr, ML, Fehily, AM, Gilbert, JF, et al. Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989; 2: 757–61.
105Gillman, MW, Cupples, LA, Millen, BE, et al. Inverse association of dietary fat with development of ischaemic stroke in men. Journal of the American Medical Association 1997; 278: 2145–50.
106Orenica, AJ, Daviglus, ML, Dyer, AR, et al. Fish consumption and stroke in men. Stroke 1996; 27: 204–9.
107Zhang, J, Sasaki, S, Amano, K, Kesteloot, H. Fish consumption and mortality from all causes, ischaemic heart disease and stroke: an epidemiological study. Preventive Medicine 1999; 28: 520–9.
108Kris-Etherton, PM, Zhao, G, Binkoski, AE, et al. The effects of nuts on coronary heart disease risk. Nutrition Reviews 2001; 59: 103–11.
109Fraser, GE, Sabate, J, Beeson, WL, Strahan, TM. A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study. Archives of Internal Medicine 1992; 152: 1416–24.
110Fraser, GE, Lindsted, KD, Beeson, WL. Effect of risk factor values on lifetime risk of and age at that first coronary event. The Adventist Health Study. American Journal of Epidemiology 1995; 142: 746–58.
111Hu, FB, Stamfer, MJ. Nut consumption and risk of coronary heart disease: a review of epidemiologic evidence. Current Atherosclerosis Reports 1999; 1: 204–9.
112Anderson, JW, Smith, BM, Washnok, CS. Cardiovascular and renal benefits of dry bean and soybean intake. American Journal of Clinical Nutrition 1999; 70(Suppl.): S464–74.
113Third International, Symposium on the role of soy in preventing and treating chronic disease. Journal of Nutrition 2000; 130(Suppl.): S653–711.
114Anthony, MS, Clarkson, TB, Bullock, BC. Soy protein versus soy phitoestrogens (isoflavones) in the prevention of coronary artery atherosclerosis of cyno molgus monkeys (Abstract). Circulation 1996; 94(Suppl. 1): 1–265.
115Crouse, JR III, Morgan, T, et al. Randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Archives of Internal Medicine 1999; 159: 2070–6.
116Davies, DF. Cow's milk antibodies and coronary heart disease. Lancet 1980; 8179: 1190–1.
117Law, MR, Wald, N. 1994; An ecological study of serum cholesterol and ischaemic heart disease between 1850 and 1990. European Journal of Clinical Nutrition 48: (5) 305–25.
118Seely, S. Diet and coronary disease. A survey of mortality rates and food consumption statistics of 24 countries. Medical Hypotheses 1981; 7: 907–18.
119Abbott, RD, Curb, JD, Rodriguez, BL, et al. Effect of dietary calcium and milk consumption on risk of thromboembolic stroke in older middle aged men. Stroke 1996; 27: 813–8.
120Gaziano, JM, Buring, JE, Breslow, JL, et al. Moderate alcohol intake, increased levels of high–density lipoprotein and its subfractions, and decreased risk of myocardial infarction. New England Journal of Medicine 1993; 329: 1829–34.
121Rehm, J, Bondy, S. Alcohol and all cause mortality: an overview. Novartis Foundation Symposium 1998; 216: 223–32.
122Gaziano, JM, Godfried, S, Hennekens, CH. Alcohol and coronary heart disease. Trends in Cardiovascular Medicine 1996; 329: 1829–34.
123Maclure, M. Demonstration of deductive meta–analysis: ethanol intake and risk of myocardial infarction. Epidemiologic Reviews 1993; 15: 328–51.
124Moore, RD, Pearson, T. Moderate alcohol consumption and coronary artery disease: a review. Medicine 1986; 65: 242–67.
125Sacco, RL, Elkind, Mm, Boden-Albala, B, et al. The protective effect of moderate alcohol consumption on ischemic stroke. Journal of the American Medical Association 1999; 281: 53–60.
126Gaziano, JM, Buring, JE, Brestlow, JL, Goldhaber, SZ. Moderate alcohol intake increased levels of high–density lipoprotein and its subfractions, and decreased risk of myocardial infarction. New England Journal of Medicine 1993; 329: 1829–34.
127Gaziano, JM, Hennekens, CH, Godfried, SL, et al. Type of alcoholic beverage and risk of myocardial infarction. American Journal of Cardiology 1999; 83: 52–7.
128Miyagi, Y, Miwa, K, Inoue, H. Inhibition of human low–density lipoprotein oxidation by flavonoids in red wine and grape juice. American Journal of Cardiology 1997; 80: 1627–31.
129Hu, FB, Stampfer, MJ, Rimm, EB, et al. A prospective study of egg consumption and risk of cardiovascular disease in men and women. Journal of the American Medical Association 1999; 281(15): 1387–94.
130Trichopoulou, A, Kouris-Blazos, A, Vassilakou, T, et al. The diet and survival of elderly Greeks; a link to the past. American Journal of Clinical Nutrition 1995; 61(Suppl. 1): 346S–50S.
131Keys, A, Menotti, A, Karvonen, MJ, et al. The diet and 15–year death rate in the Seven Countries Study. American Journal of Epidemiology 1986; 124: 903–15.
132Trichopoulou, A, Vasilopoulou, E. Mediterranean diet and longevity. British Journal of Nutrition 2000; 84(Suppl. 2): S205–9.
133De, Lorgeril, Renaud, S, Mamelle, N, et al. Mediterranean alpha–linolenic acid–rich diet in secondary prevention of coronary heart disease. Lancet 1994; 343: 1454–9.
134Rimm, EB, Ascherio, A, Giovannucci, E, et al. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. Journal of the American Medical Association 1996; 275: 447.
135Gilman, MW, Cupples, LA, Gagnon, DJ, et al. Protective effect of fruits and vegetables on development of stroke in men. Journal of the American Medical Association 1995; 273: 1113–7.
136Willett, WC. Convergence of philosophy and science: the Third International Congress on Vegetarian Nutrition. American Journal of Clinical Nutrition 1999; 70(Suppl. 43): 4S–8S.
137Pais, P, Pogue, J, Gerstein, H, Zachariah, E, et al. Risk factors for acute myocardial infarction in Indians: a case–control study. Lancet 1996; 348: 358–63.
138Hu, FB, Rimm, EB, Stampfer, MJ, et al. Prospective study of major dietary patterns and risk of coronary heart disease in men. American Journal of Clinical Nutrition 2000; 72: 912–21.
139Moore, TJ, Conlin, PR, Ard, J, Svetkey, LP. for DASH Collaborative Research Group, DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension. Hypertension 2001; 38: 155–8.
140Obarzanek, E, Sacks, FM, Vollmer, WM, et al. Effects on blood lipids of a blood pressure–lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. American Journal of Clinical Nutrition 2001; 74: 80–9.
141Shimamoto, T, Komachi, Y, Inada, H, et al. Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation 1989; 79: 503–15.
142Truswell, AS. Review of dietary intervention studies: effect on coronary events and on total mortality. Australian and New Zealand Journal of Medicine 1994; 24: 98–106.
143Zatonski, WA, McMichael, AJ, Powles, JW. Ecological study of reasons for sharp decline in mortality for ischaemic heart disease in Poland since 1991. British Medical Journal 1998; 317: 678.
144Pietinen, P, Vartianinen, E, Seppanen, R, et al. Changes in diet in Finland from 1972 to 1992: impact on coronary heart disease risk. Preventive Medicine 1996; 25: 243–50.
145Dowsen, GK, Gareeboo, H, George, K, et al. Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of non–communicable disease intervention programme in Mauritius. British Medical Journal 1995; 311: 1255–9.
146Drewnowski, A, Popkin, BM. The nutrition transition: new trends in the global diet. Nutrition Reviews 1997; 55: 31–43.
147Indu, M, Ghafoornissa, . Fatty acids in Indian diets—comparison of the effects of precursor (alpha–linolenic acid) vs product (long chain n–3 poly unsaturated fatty acids). Nutrition Research 1992; 12: 569–82.
148Lang, T. The public health impact of globalisation of food trade. In: Shetty, PS, McPherson, K, eds. Diet, Nutrition and Chronic Disease. Lessons from Contrasting Worlds. Chichester: Wiley, 1997; 173–87.